VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | Mechanisms of resistance to immunotherapy in NHL

Nilanjan Ghosh, MD, PhD, Atrium Health Levine Cancer Institute, Charlotte, NC, briefly discusses mechanisms of resistance to immunotherapy in non-Hodgkin lymphoma (NHL), drawing focus on T-cell exhaustion, myeloid-derived suppressor cells, and antigen escape. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Disclosures

Research funding, honoraria, consulting: BMS
Consulting: Lilly, Genentech/Roche

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter